Baxter International BAX
NYSE BAX
$26.34 -0.07 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Baxter International (BAX) Cash from Financing Activities (2009 - 2026)

Baxter International (BAX) posted quarterly Cash from Financing Activities of -$31.0 million for Q2 2026, up 95.93% year-over-year from -$15.8 million in Q2 2025, and down 181.82% quarter-over-quarter from -$11.0 million in Q1 2026.

Baxter International (BAX) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Baxter International (BAX) has reported Cash from Financing Activities for 18 consecutive years, with -$31.0 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash from Financing Activities rose 95.93% year-over-year to -$31.0 million; the TTM figure through Jun 2026 stood at -$270.0 million (up 93.24% YoY), while the FY2025 annual figure was -$4.2 billion, down 290.01% from the prior year.
  • Cash from Financing Activities fell to -$31.0 million in Q2 2026 per BAX's latest filing, from -$11.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $141.0 million in Q4 2024 and bottomed at -$3.2 billion in Q1 2025.
  • Historically, Cash from Financing Activities has averaged -$570.3 million across 5 years, with a median of -$146.5 million in 2024.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 2366.39% — and 2024, when it surged 104.8%.
  • Baxter International's Cash from Financing Activities stood at -$119.0 million in 2022, then sank by 2366.39% to -$2.9 billion in 2023, then soared by 104.8% to $141.0 million in 2024, then plunged by 204.26% to -$147.0 million in 2025, then jumped by 78.91% to -$31.0 million in 2026.
  • Business Quant data shows BAX's Cash from Financing Activities at -$31.0 million in Q2 2026, -$11.0 million in Q1 2026, and -$147.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -287.90 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -577.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -510.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -263.16 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -159.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -164.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -300.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -75.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -31.00 Mn
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -67.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -31.00 Mn
Jun 30, 2026 -31.00 Mn
Mar 31, 2026 -11.00 Mn
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 -147.00 Mn
Dec 31, 2025 -147.00 Mn
Sep 30, 2025 -81.00 Mn
Sep 30, 2025 -81.00 Mn
Jun 30, 2025 -762.00 Mn
Jun 30, 2025 -762.00 Mn
Mar 31, 2025 -3.23 Bn
Mar 31, 2025 -3.23 Bn
Dec 31, 2024 141.00 Mn
Dec 31, 2024 141.00 Mn
Sep 30, 2024 -146.00 Mn
Sep 30, 2024 -146.00 Mn
Jun 30, 2024 -936.00 Mn
Jun 30, 2024 -936.00 Mn
Mar 31, 2024 -140.00 Mn
Mar 31, 2024 -140.00 Mn